• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检查点激酶Chk1对蛋白激酶CK2调节性β亚基的磷酸化:体外CK2β磷酸化位点的鉴定

Phosphorylation of the regulatory beta-subunit of protein kinase CK2 by checkpoint kinase Chk1: identification of the in vitro CK2beta phosphorylation site.

作者信息

Kristensen Lars P, Larsen Martin R, Højrup Peter, Issinger Olaf-Georg, Guerra Barbara

机构信息

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark.

出版信息

FEBS Lett. 2004 Jul 2;569(1-3):217-23. doi: 10.1016/j.febslet.2004.05.069.

DOI:10.1016/j.febslet.2004.05.069
PMID:15225637
Abstract

The regulatory beta-subunit of protein kinase CK2 mediates the formation of the CK2 tetrameric form and it has functions independent of CK2 catalytic subunit through interaction with several intracellular proteins. Recently, we have shown that CK2beta associates with the human checkpoint kinase Chk1. In this study, we show that Chk1 specifically phosphorylates in vitro the regulatory beta-subunit of CK2. Chymotryptic peptides and mutational analyses have revealed that CK2beta is phosphorylated at Thr213. Formation of a stable complex between CK2beta and Chk1 is not affected by the modification of Thr213 but it does require the presence of an active Chk1 kinase.

摘要

蛋白激酶CK2的调节性β亚基介导CK2四聚体形式的形成,并且通过与几种细胞内蛋白质相互作用而具有独立于CK2催化亚基的功能。最近,我们已经表明CK2β与人类检查点激酶Chk1相关联。在本研究中,我们表明Chk1在体外特异性磷酸化CK2的调节性β亚基。胰凝乳蛋白酶肽段和突变分析表明CK2β在Thr213处被磷酸化。CK2β与Chk1之间稳定复合物的形成不受Thr213修饰的影响,但确实需要活性Chk1激酶的存在。

相似文献

1
Phosphorylation of the regulatory beta-subunit of protein kinase CK2 by checkpoint kinase Chk1: identification of the in vitro CK2beta phosphorylation site.检查点激酶Chk1对蛋白激酶CK2调节性β亚基的磷酸化:体外CK2β磷酸化位点的鉴定
FEBS Lett. 2004 Jul 2;569(1-3):217-23. doi: 10.1016/j.febslet.2004.05.069.
2
Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.蛋白激酶CK2的调节性β亚基对人类检查点激酶Chk1的调节作用。
Oncogene. 2003 Aug 7;22(32):4933-42. doi: 10.1038/sj.onc.1206721.
3
The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.蛋白激酶CK2调节亚基的多重特性:CK2依赖性和非依赖性作用揭示了CK2β的隐秘身份。
Int J Biol Sci. 2005;1(2):67-79. doi: 10.7150/ijbs.1.67. Epub 2005 Apr 1.
4
The 'regulatory' beta-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation.蛋白激酶CK2的“调节性”β亚基对p53介导的Chk2激活的变构效应产生负面影响。
Oncogene. 2005 Sep 8;24(40):6194-200. doi: 10.1038/sj.onc.1208762.
5
Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.细胞周期调节蛋白p27KIP1是一种底物,可与蛋白激酶CK2相互作用。
J Cell Biochem. 2004 Apr 1;91(5):865-79. doi: 10.1002/jcb.20027.
6
The activity of CK2 in the extracts of COS-7 cells transfected with wild type and mutant subunits of protein kinase CK2.用蛋白激酶CK2的野生型和突变亚基转染的COS-7细胞提取物中CK2的活性。
Mol Cell Biochem. 2001 Nov;227(1-2):37-44.
7
The regulatory beta subunit of protein kinase CK2 mediates formation of tetrameric CK2 complexes.蛋白激酶CK2的调节性β亚基介导四聚体CK2复合物的形成。
J Biol Chem. 2000 Feb 18;275(7):5003-10. doi: 10.1074/jbc.275.7.5003.
8
Protein kinase CK2 regulates CDC25B phosphatase activity.蛋白激酶CK2调节细胞分裂周期蛋白25B磷酸酶的活性。
Oncogene. 2003 Jan 16;22(2):220-32. doi: 10.1038/sj.onc.1206107.
9
Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta.蛋白激酶CK2的组装:使用CK2β锌指缺陷型突变体研究催化亚基与调节亚基之间的复合物形成
Biochem J. 2001 Aug 15;358(Pt 1):87-94. doi: 10.1042/0264-6021:3580087.
10
Functions of the C-terminal domain of CTP: phosphocholine cytidylyltransferase. Effects of C-terminal deletions on enzyme activity, intracellular localization and phosphorylation potential.CTP:磷酸胆碱胞苷转移酶C末端结构域的功能。C末端缺失对酶活性、细胞内定位和磷酸化潜力的影响。
Biochem J. 1995 Sep 1;310 ( Pt 2)(Pt 2):699-708. doi: 10.1042/bj3100699.

引用本文的文献

1
Casein Kinase 2 Signaling in White Matter Stroke.白质卒中中的酪蛋白激酶2信号传导
Front Mol Biosci. 2022 Jul 13;9:908521. doi: 10.3389/fmolb.2022.908521. eCollection 2022.
2
Combining Recombinase-Mediated Cassette Exchange Strategy with Quantitative Proteomic and Phosphoproteomic Analyses to Inspect Intracellular Functions of the Tumor Suppressor Galectin-4 in Colorectal Cancer Cells.结合重组酶介导的盒式交换策略与定量蛋白质组学和磷酸化蛋白质组学分析,检测肿瘤抑制因子半乳糖凝集素-4在结直肠癌细胞中的细胞内功能。
Int J Mol Sci. 2022 Jun 8;23(12):6414. doi: 10.3390/ijms23126414.
3
Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups.
解码人类髓母细胞瘤亚组中的体细胞驱动基因突变及受影响的信号通路。
J Cancer. 2018 Nov 17;9(24):4596-4610. doi: 10.7150/jca.27993. eCollection 2018.
4
CK2 inhibition protects white matter from ischemic injury.CK2抑制可保护白质免受缺血性损伤。
Neurosci Lett. 2018 Nov 20;687:37-42. doi: 10.1016/j.neulet.2018.08.021. Epub 2018 Aug 17.
5
Roles of Chk1 in cell biology and cancer therapy.Chk1 在细胞生物学和癌症治疗中的作用。
Int J Cancer. 2014 Mar 1;134(5):1013-23. doi: 10.1002/ijc.28226. Epub 2013 May 28.
6
Casein kinase 2beta as a novel enhancer of activin-like receptor-1 signaling.酪蛋白激酶2β作为激活素样受体-1信号传导的新型增强剂。
FASEB J. 2009 Nov;23(11):3712-21. doi: 10.1096/fj.09-131607. Epub 2009 Jul 10.
7
Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN.DNA停滞后细胞重新进入细胞周期的决定是由Chk1和PTEN的位点特异性磷酸化所介导的。
Mol Cancer Ther. 2008 Aug;7(8):2509-16. doi: 10.1158/1535-7163.MCT-08-0199.
8
The emerging CK2 interactome: insights into the regulation and functions of CK2.新兴的CK2相互作用组:对CK2调控及功能的见解
Mol Cell Biochem. 2008 Sep;316(1-2):5-14. doi: 10.1007/s11010-008-9830-5. Epub 2008 Jun 14.
9
Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.前列腺癌细胞系中蛋白激酶CK2β亚基的免疫定义亚类
Mol Cell Biochem. 2005 Jun;274(1-2):181-7. doi: 10.1007/s11010-005-2950-2.